Supported by a global coalition founded by India and Norway, the US has begun the phase one clinical trial of an investigational vaccine designed to protect against the coronavirus disease which has claimed the lives of over 7,000 people globally.

The trial began at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle as the first participant received the investigational vaccine.

“I’m pleased to report today that a vaccine candidate has begun the phase one clinical trial. This is one of the fastest vaccine development launches in history. Not even close. We’re also racing to develop antiviral therapies and other treatments,” Trump told reporters at a White House news conference on Monday.

Phase 1 trial
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is funding the trial. The open-label trial will enrol 45 healthy adult volunteers aged 18 to 55 years over approximately six weeks.

“Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority,” said NIAID Director Anthony S Fauci.

“This Phase 1 study, launched in record speed, is an important first step towards achieving that goal,” he said.

According to the NIH, the study is evaluating different doses of the experimental vaccine for safety and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.

The vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc., based in Cambridge, Massachusetts.

The Coalition for Epidemic Preparedness Innovations (CEPI) supported the manufacturing of the vaccine candidate for the Phase 1 clinical trial, the NIH said.

Conceived in 2015, CEPI was founded in Davos in 2017 by the governments of Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.

According to its website, CEPI so far has secured $760 million toward its $1 billion funding target, with multi-year funding from Norway, the UK, Germany, Japan, Canada, Ethiopia, Australia, the Bill & Melinda Gates Foundation, and Wellcome.

Among its 12 voting members are Cherry Gagandeep Kang from Christian Medical College Vellore and Rajeev Venkayya Vaccine Business Unit, Takeda Pharmaceutical Company Limited. Indian Soumya Swaminathan is a non-voting member and represents the World Health Organization (WHO) in the Board.

Early this week, CEPI, the organisation set up to accelerate the development of vaccines against emerging infectious diseases, made an urgent call for $2 billion to support the development of a vaccine against the virus responsible for COVID-19.

In a statement, the NIH said that infection with SARS-CoV-2, the virus that causes COVID-19, can cause a mild to severe respiratory illness and include symptoms of fever, cough and shortness of breath.

The number of deaths due to coronavirus has passed 7,000 worldwide. More than 175,530 cases have been recorded in 145 countries.

COVID-19 cases were first identified in December 2019 in China’s Wuhan in Hubei province. As of March 15, the WHO has reported 153,517 cases of COVID-19 and 5,735 deaths worldwide. More than 2,800 confirmed COVID-19 cases and 58 deaths have been reported in the United States as of March 15, according to the Centers for Disease Control and Prevention (CDC).

“Currently, no approved vaccines exist to prevent infection with SARS-CoV-2,” the NIH said, adding that investigational vaccine was developed using a genetic platform called mRNA (messenger RNA).

The investigational vaccine directs the body’s cells to express a virus protein that, it is hoped, will elicit a robust immune response. The mRNA-1273 vaccine has shown promise in animal models, and this is the first trial to examine it in humans, it said.

Scientists at NIAID’s Vaccine Research Center (VRC) and Moderna were able to quickly develop mRNA-1273 because of prior studies of related coronaviruses that cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).

The Phase 1 trial is led by Lisa A Jackson, MD, senior investigator at KPWHRI. Study participants will receive two doses of the vaccine via intramuscular injection in the upper arm approximately 28 days apart. Each participant will be assigned to receive a 25 microgram (mcg), 100 mcg or 250 mcg dose at both vaccinations, with 15 people in each dose cohort, according to a statement.

The first four participants will receive one injection with the low dose, and the next four participants will receive the 100 mcg dose. Investigators will review safety data before vaccinating the remaining participants in the 25 and 100 mcg dose groups and before participants receive their second vaccinations. Another safety review will be done before participants are enrolled in the 250 mcg cohort.

“This work is critical to national efforts to respond to the threat of this emerging virus. We are prepared to conduct this important trial because of our experience as an NIH clinical trials centre since 2007,” Dr Jackson said.

Published on March 17, 2020
USA vaccines and immunisation coronavirus
SHARE
0
COMMENTS

Previous Story

Apex court says `yes' to permanent commission for women in Navy

Next Story

Maharashtra to use indelible ink to mark people suspected of coronavirus
Comment
MOST POPULAR
JSW Steel misses deadline to pay ₹19,700 cr for BPSL buy
The Hindu Businessline
MOST POPULAR
Coronavirus outbreak: All educational institutions, malls, theatres to be shut till March 31 in Tamil Nadu
The Hindu Businessline
Not responsible for the bank’s downfall, says Rana Kapoor
The Hindu Businessline
Virus fear: Jackfruit’s market share jacks up as poultry takes a hit
The Hindu Businessline
Delhi court hears petition on staying Nibhaya hangings after convict Pawan moves for mercy
India Today
|
Sponsored
Global MBA from UK and Australia
upGrad
|
Sponsored
क्या आपकी उम्र 45-55 साल के बीच है? ₹1 करोड़ का टर्म इन्शुरन्स ₹2,500 प्रति माह. अभी संपर्क करे!
Term Life Insurance
|
Sponsored
Coronavirus scare: Maharashtra farmer dumps ₹5.8-crore worth poultry products after drop in sales
The Hindu Businessline
Mukesh Ambani loses Asia’s richest man crown to Ma
The Hindu Businessline
YES Bank retail investors too face three-year lock-in
The Hindu Businessline
Born between 1960-1975? Rs.1cr Term Insurance Cover at Just Rs.2500/Month*. Get Quote!
Term Life Insurance
|
Sponsored
Born Between 1965-1985? Get Term Life Insurance Worth ₹1 Cr at Rs.1884/month*.
Policybazaar.com
|
Sponsored
A Drink That Melts Fat! घटाइए १० kg वजन सिर्फ ४ हफ़्तों में!
Keto
|
Sponsored
Work From Home Jobs Might Earn You More Than You Think
Online Jobs | Search Ads
|
Sponsored
Greatest Cricket Batsmen of All Time, Ranked
Stadium Talk
|
Sponsored
Covid-19: Cases in India climb to 107, Maharashtra tops the list
The Hindu Businessline
Covid-19 threat: Karnataka orders shutdown of malls, multiplexes, public gatherings for a week
The Hindu Businessline
Protect Your Home From Pests - like Mosquitoes, Flies, Spiders, Ants, Cockroaches, Rats, and Rodents
Insectkillers
|
Sponsored
Online Jobs Might Pay More Than You Think
Online Jobs | Search Ads
|
Sponsored
The Cost of Apartments in Las Vegas Might Surprise You
Apartments in Las Vegas | Search Ads
|
Sponsored
MOST POPULAR
Is India running too few coronavirus tests?
The Hindu Businessline
MOST POPULAR
Coronavirus: Singapore Airlines offers waivers for rebooking of tickets
The Hindu Businessline
Covid-19 has an incubation period of 5.1 days, says study
The Hindu Businessline
YES Bank will be back on growth track in two quarters: Administrator Prashant Kumar
The Hindu Businessline
Cost of Dubai Properties Might Amaze You
Dubai Properties | Search Ads
|
Sponsored
Best Places in India where you can Settle Down after Retirement
VT Settle
|
Sponsored
Experts Share Why Prebiotics Are Good For Infants | Read Now
Danone India
|
Sponsored
Rahul Gandhi slams Centre’s response to coronavirus outbreak
The Hindu Businessline
YES Bank’s proposed reconstruction plan raises many questions
The Hindu Businessline
Flat Prices in Gurgaon Might Actually Surprise You
Flats for Sale | Search Ads
|
Sponsored
People from India cannot believe these flight prices
Trips Shop
|
Sponsored
Most Expensive Dogs in the World, Ranked
Work + Money
|
Sponsored

Recommended for you

Covid-19: No work from home for Pune’s IT employees?

Delhi HC to hear pleas for drafting uniform civil code next week

Bombay HC to hear aggrieved Yes Bank AT-1 bond holders today

Chief Justice rules out Supreme Court shut-down amidst coronavirus scare

Covid-19: Cases in India climb to 107, Maharashtra tops the list
LATEST IN NEWS

Healthy storage levels in dams leave Maharashtra’s water tanker lobby worried
Dams in Maharashtra now have 57 per cent water storage, compared to 30 per ...


‘Fleeing’ coronavirus patients add to Maharashtra’s challenges
State government seeks to make hospital quarantine ‘comfortable’


Government nominates ex-CJI Ranjan Gogoi to Rajya Sabha
A notification announcing his nomination to the Upper House was issued by ...


Coronavirus outbreak: Educational institutions, malls, recreational spots to be shut in TN
The Tamil Nadu government has ordered the closure of education ...


West Bengal to have Rs 200 crore fund to tackle coronavirus, says Mamata Banerjee
West Bengal Chief Minister Mamata Banerjee announced the State government ...


Telangana Assembly adopts resolution against CAA, NPR, NRC
The Telangana Legislative Assembly on Monday adopted a resolution against ...


Apex court says `yes' to permanent commission for women in Navy
Maintaining that women and men officers should be treated equally, the ...


US begins clinical trial of vaccine for coronavirus
Supported by a global coalition founded by India and Norway, the US has ...


Maharashtra to use indelible ink to mark people suspected of coronavirus
The state government of Maharashtra has decided on Monday to stamp the left ...


ICMR checking the possibility of third stage of COVID-19 spread in India
The Indian Council of Medical Research (ICMR) has started collecting random ...

MOST POPULAR
MOST SHARED
MOST COMMENTED
Covid-19: No work from home for Pune’s IT employees?
Even as the Maharashtra government has declared coronavirus an epidemic, majority of over 3 lakh IT ...

Coronavirus outbreak: Educational institutions, malls, recreational spots to be shut in TN
The Tamil Nadu government has ordered the closure of education institutions, malls, amusement parks, ...

West Bengal to have Rs 200 crore fund to tackle coronavirus, says Mamata Banerjee
West Bengal Chief Minister Mamata Banerjee announced the State government will create a ₹200 crore ...

Will give ₹5 crore to anyone who can prove eating chicken and eggs causes viral infection: Pune retailer
Consumption decline sees retail prices crash to ₹10 per kg in some parts of Pune

by TaboolaPromoted Links
You May Like
Delhi court hears petition on staying Nibhaya hangings after convict Pawan moves for mercy
India Today
Global MBA from UK and Australia
upGrad
जन्म 1970-1990 के बीच? ₹ 1 Cr टर्म इंश्योरेंस @ ₹1450 प्रति माह*. अभी संपर्क करे!
Term Life Insurance
Born Between 1965-1985? Get Term Life Insurance Worth ₹1 Cr at Rs.1884/month*.
Policybazaar.com
A Drink That Melts Fat! घटाइए १० kg वजन सिर्फ ४ हफ़्तों में!
Keto
Work From Home Jobs Might Earn You More Than You Think
Online Jobs | Search Ads
Not responsible for the bank’s downfall, says Rana Kapoor
Virus fear: Jackfruit’s market share jacks up as poultry takes a hit
Coronavirus scare: Maharashtra farmer dumps ₹5.8-crore worth poultry products after drop in sales
Mukesh Ambani loses Asia’s richest man crown to Ma
Specials
Portfolio
BL Ink
Catalyst
India File
You won't miss your flight, thanks to floorwalkers
Floorwalkers help round up the missing passengers during boarding

Ever think of the engine that powers your aircraft?
The engine plays a key role in the overall plane design. Tune in to its sounds the next time you fly!

Plenty in the pipeline: Detect gears to crack the US oil and gas market
The start-up’s two main products — GUMPS and Noctua — have been commercially deployed in India

Medicos turned techies make school admissions smoother
SchoolSkies helps in automating the admission and fee payment process

Big Story | The 6 best endowment plans: Protect your capital and get guaranteed returns
Subscribe to The Hindu BusinessLine to read more. REMIND ME LATER

Big Story | The 6 best endowment plans: Protect your capital and get guaranteed returns


Subscribe to The Hindu BusinessLine to read more and understand from.............................BL